Reclast, Zometa (zoledronate) Reduced Fractures in Osteopenic Older Women

MedicalResearch.com Interview with:

Prof Ian Reid Faculty of Medical and Health Sciences University of Auckland Auckland New Zealand

Prof. Reid

Prof Ian Reid MD
Faculty of Medical and Health Sciences
University of Auckland
Auckland New Zealand


MedicalResearch.com: What is the background for this study? 

Response: Bisphosphonates prevent fractures in patients with osteoporosis, but their efficacy in women with osteopenia is unknown. Most fractures in postmenopausal women occur in osteopenic patients, so therapies with efficacy in osteopenia are needed.

Continue reading